ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today announced that the company will deliver ...

ANN ARBOR, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Secondary techniques are needed to address macular holes in patients with myopia, according to a speaker at OSN New York ...

KUALA LUMPUR - Individuals aged 40 and above, particularly those with high myopia (nearsightedness), a history of eye injury, or who have undergone eye surgery, are at a higher risk of developing ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition affects the back of the eye where light is processed by ...

A clinical trial led by Stanford University School of Medicine has demonstrated that a wireless retinal prosthesis can help restore vision lost to advanced macular degeneration. The results, published ...

A new study in The New England Journal of Medicine revealed that the PRIMA brain computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some ...

In a landmark study, a wireless retinal implant helped most participants with severe vision loss regain the ability to read, marking a major advance toward sight restoration for age-related macular ...

The inverted ILM flap technique yields better macular hole closure than ILM peeling for some high myopic macular holes.